The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...
The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a ...
The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...
The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's influenza nasal spray vaccine for ...
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...
The latest trading day saw Astrazeneca (AZN) settling at $78.38, representing a -0.66% change from its previous close.
The AstraZeneca PLC ADR AZN slumped 0.66% to $78.38 Friday, on what proved to be an all-around mixed trading session for the ...
FluMist is the only flu vaccine administered by nasal spray, not injection. It is licensed for individuals between the ages ...
AstraZeneca has announced that FluMist has been approved in the US as the self-administered influenza vaccine. FluMist, a ...